**Core Concept**
Generalized tonic-clonic seizures (GTCS) in systemic lupus erythematosus (SLE) are often linked to autoimmune antibodies that target neuronal proteins, leading to central nervous system dysfunction. Among these, anti-neuronal antibodies are specifically associated with seizure activity in SLE patients.

**Why the Correct Answer is Right**
Anti-neuronal antibodies (e.g., anti-GAD, anti-Hu, anti-NMDA receptor) are known to cross the blood-brain barrier and directly affect neuronal function, potentially causing epileptiform activity. In SLE, these antibodies can be present in the context of CNS involvement and are strongly correlated with GTCS. Their pathophysiological role involves disrupting synaptic transmission and inducing hyperexcitability in brain circuits.

**Why Each Wrong Option is Incorrect**
Option B: Anti-Ro (SSA) antibodies are primarily associated with Sjögren’s syndrome, neonatal lupus, and photosensitivity, not directly with GTCS.
Option C: Anti-Sm antibodies are highly specific for SLE but are not linked to seizure activity; they are more associated with renal and serosal involvement.
Option D: "None" is incorrect because anti-neuronal antibodies *are* documented in SLE-related GTCS.

**Clinical Pearl / High-Yield Fact**
In SLE patients presenting with seizures, anti-neuronal antibodies should be tested—especially if there’s no clear history of trauma or infection. These antibodies are a key clue for autoimmune encephalitis in the context of lupus.

✓ Correct Answer: A. Anti neuronal ab